Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurel Perren

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Swiss Medical Weekly|February 8, 2020
Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647Anita Feller, Matthias Bopp, Matthias Lorez, et al.
NPJ Precision Oncology|March 1, 2024
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapiesSimon L April-Monn, Philipp Kirchner, Katharina Detjen, et al.
The American Journal of Surgical Pathology|November 18, 2008
Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemiaMartin Anlauf, Juliane Bauersfeld, Andreas Raffel, et al.
Biology|April 5, 2020
Assessing Autophagy in Archived Tissue or How to Capture Autophagic Flux from a Tissue SnapshotMagali Humbert, María Morán, Patricia de la Cruz-Ojeda, et al.
Annals of Surgical Oncology|November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?Elettra Merola, Anja Rinke, Stefano Partelli, et al.
Neuroendocrinology|April 3, 2020
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine TumorsSimon Leonhard April-Monn, Tabea Wiedmer, Magdalena Skowronska, et al.
International Journal of Cancer|February 5, 2026
Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomasSiren Morken, Seppo W Langer, Geir Olav Hjortland, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
British Journal of Cancer|July 14, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 studyHalfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, et al.
British Journal of Cancer|May 27, 2026
Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damageElham Kashani, Martin C Sadowski, Jaison Phour, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Swiss Medical Weekly|February 8, 2020
Comment on: Wiser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Swiss Med Wkly.2018;148:w14647Anita Feller, Matthias Bopp, Matthias Lorez, et al.
NPJ Precision Oncology|March 1, 2024
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapiesSimon L April-Monn, Philipp Kirchner, Katharina Detjen, et al.
The American Journal of Surgical Pathology|November 18, 2008
Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemiaMartin Anlauf, Juliane Bauersfeld, Andreas Raffel, et al.
Biology|April 5, 2020
Assessing Autophagy in Archived Tissue or How to Capture Autophagic Flux from a Tissue SnapshotMagali Humbert, María Morán, Patricia de la Cruz-Ojeda, et al.
Annals of Surgical Oncology|November 14, 2019
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?Elettra Merola, Anja Rinke, Stefano Partelli, et al.
Neuroendocrinology|April 3, 2020
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine TumorsSimon Leonhard April-Monn, Tabea Wiedmer, Magdalena Skowronska, et al.
International Journal of Cancer|February 5, 2026
Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomasSiren Morken, Seppo W Langer, Geir Olav Hjortland, et al.
Nature Communications|October 28, 2025
DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasmsBenjamin Goeppert, Alphonse Charbel, Reka Toth, et al.
British Journal of Cancer|July 14, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 studyHalfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, et al.
British Journal of Cancer|May 27, 2026
Targeting the miR-19b/PPP2R5E axis enhances temozolomide response in glioblastoma via ROS-induced DNA damageElham Kashani, Martin C Sadowski, Jaison Phour, et al.
Pageof 24